Navigation Links
New ANTEK MultiTek(TM) by PAC Provides Fast, All-in-One Testing for Sulfur, Nitrogen, Halides
Date:10/5/2009

and ensure product compliance across a wide range of industries and applications, from fuels to pharmaceuticals to 'green' manufacturing. MultiTek(TM) is part of PAC's well-established ANTEK product line.

About PAC

PAC is a dominant global provider of advanced analytical instruments for laboratories and online process applications. With a product portfolio of over 200 instruments, PAC serves industries such as refinery, petrochemical, biofuels, environmental, food & beverage and pharmaceutical. To provide its customers with cutting edge technology, PAC leverages significant R&D resources to support its core technologies, including chromatography, elemental analysis, physical properties and software applications. PAC's product portfolio includes AC Analytical Controls, ANTEK, Alcor, PetrosSpec, PSPI, ISL and Walter Herzog. For more information, visit www.paclp.com, or contact the company's headquarters at 8824 Fallbrook Dr., Houston, Texas 77064, Tel. (U.S.) 800.444.TEST, or +281.940.1803.

    Contact:
    Michael L. Martel
    MMC, Inc. for PAC
    401-480-3433

SOURCE PAC


'/>"/>
SOURCE PAC
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. BioCryst Provides Update Regarding Peramivir for Influenza
2. New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of PLAVIX(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty
3. Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
4. Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA
5. Cyberonics Provides Update on Depression Post-Approval Study
6. Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl)
7. Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing
8. Alfacell Provides Shareholder Update
9. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
10. Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting
11. Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 inhibitor ... both dose groups. The primary endpoint assessed the proportion ... with data reported in previous trials, the most common ... results will be presented at an upcoming medical congress. ...
(Date:5/17/2013)... -- Sinovac Biotech Ltd. (Nasdaq: SVA ), a ... today announced that it will release its unaudited financial results ... on Tuesday, May 28, 2013.  The Company will host a ... EDT (May 28, 2013 at 8:00 p.m. China Standard Time) ... on recent corporate developments. To access the conference ...
(Date:5/16/2013)... and ZURICH , May 17, 2013 /PRNewswire/ ... Science, Technology and Research (A*STAR) and Switzerland,s ... volunteer has been dosed in a Phase 1 clinical trial ... bacteriophage Qbeta virus-like particle (VLP) technology. In this first Phase ... vaccine candidate and its potential to protect against H1N1 influenza ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
(Date:5/19/2013)... ATS 2013, PHILADELPHIA ─ Gourmands and foodies everywhere have ... a little peppery zing to both sweet and savory ... shows purified components of the spicy root also may ... , The results of the study will be presented ... characterized by bronchoconstriction, a tightening of the bronchial tubes ...
(Date:5/19/2013)... In partnership with the medical practice online marketing company, ... an SEO website for dentists. The purpose of the site ... http://www.e-dentists.com/ , A perk to the service is ... see results. Dentists can request the keywords they want included ... Media Surge, LLC rank high for competitive keywords. Dentists can ...
(Date:5/19/2013)... 19, 2013 According to a ... and Forecast (2013 – 2018): By Applications (Healthcare ... Technology (CCD, CMOS, Contact IS, Infrared, X-Ray) And ... sensor market was $8.00 billion in 2012 and ... at an estimated CAGR of 3.84% from 2013 ...
(Date:5/19/2013)... York (PRWEB) May 19, 2013 The ... Case Management Conference was recently convened for hundreds of ... multidistrict litigation now underway in U.S. District Court, Southern ... the Court’s website on May 14th, the Conference addressed ... was also reported during the Conference that Defendants submitted ...
(Date:5/19/2013)... Vegas Hotel Escapes, the premier ... the launch it's all new vacation packages for the ... 5/19/2013. Consumers traveling to Las Vegas will be pleased ... VegasHotelEscapes.com's website. Travelers will be pleased to know that ... , Vegas Hotel Escapes specializes in helping consumers ...
Breaking Medicine News(10 mins):Health News:Ginger compounds may be effective in treating asthma symptoms 2Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3
... health centers have become the centerpiece of the nation,s efforts ... experience a greater need for primary care providers, who already ... Center (BMC) and Boston University School of Medicine (BUSM) medical ... center mission to address this need. This call to action ...
... Supporting a worthy cause can make great wine taste even ... partnership with Beringer Vineyards and the Pennsylvania Breast Cancer Coalition, ... of donation during Breast Cancer Awareness Month. , During ... Beringer White Zinfandel and White Merlot sold in PA Wine ...
... Committee handed a major victory to the health care industry ... a "public option" to compete against private health insurance providers ... system. The industry has fought the public option with lobbying ... fearing that the proposed policy would cut into their record ...
... Noted Healthcare Entrepreneur Alan B. Miller is a Fitting ... his Ideas , WILLIAMSBURG, Va., Sept. 30 The ... host the grand opening and public dedication of its exceptional ... 2009. , (Logo: http://www.newscom.com/cgi-bin/prnh/20051111/DCF019LOGO-b ) , ...
... October 5, 2009, 12 Noon Central Time , ... Hospital Patient Safety Organization and Mark J. Neuberger, Foley & ... is almost upon us and companies across the globe are ... influenza pandemic plan as we await the arrival of the ...
... Sept. 30 Select Medical Holdings Corporation ("Select") (NYSE: ... that it successfully completed its initial public offering of common ... sold 30,000,000 shares in the offering. Select,s stock began ... 2009 under the Symbol "SEM." , Total net proceeds to ...
Cached Medicine News:Health News:A need for leadership in primary care 2Health News:PLCB, PA Breast Cancer Coalition, Beringer Wine Partner To Support Breast Cancer Awareness 2Health News:Insurance Industry Successful in Initial Fight Against Public Option; Public Feels Left Out 2Health News:Insurance Industry Successful in Initial Fight Against Public Option; Public Feels Left Out 3Health News:Revolutionary B-School Building, Named for Healthcare Entrepreneur Alan B. Miller, To Be Dedicated 2Health News:Revolutionary B-School Building, Named for Healthcare Entrepreneur Alan B. Miller, To Be Dedicated 3Health News:Society of Corporate Compliance and Ethics to host What Compliance Professionals Need to Know about H1N1 Web Conference 2Health News:Society of Corporate Compliance and Ethics to host What Compliance Professionals Need to Know about H1N1 Web Conference 3Health News:Select Medical Holdings Corporation Successfully Completes Initial Public Offering of Common Stock 2
... Used retrograde to ... establish a Peel-Away ureteral ... The temporary protective Peel-Away ... away as the ureteroscope ...
The removable inflation/injection adapter allows the cystoscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
Radiopaque markers are placed at the proximal and distal ends of the balloon. A special pin vise handle is included to stabilize the wire guide during introduction. Supplied sterile in peel-open pack...
Used during the performance of balloon dilation procedures to inflate and deflate the balloon and measure the pressure within the balloon during the procedure. Supplied sterile in peel-open packages....
Medicine Products: